IRON
Price
$60.76
Change
+$0.57 (+0.95%)
Updated
Sep 5 closing price
Capitalization
2.11B
61 days until earnings call
KALV
Price
$15.82
Change
+$0.62 (+4.08%)
Updated
Sep 5 closing price
Capitalization
796.38M
5 days until earnings call
Interact to see
Advertisement

IRON vs KALV

Header iconIRON vs KALV Comparison
Open Charts IRON vs KALVBanner chart's image
Disc Medicine
Price$60.76
Change+$0.57 (+0.95%)
Volume$196.29K
Capitalization2.11B
KalVista Pharmaceuticals
Price$15.82
Change+$0.62 (+4.08%)
Volume$1.08M
Capitalization796.38M
IRON vs KALV Comparison Chart in %
Loading...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KALV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRON vs. KALV commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRON is a Hold and KALV is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (IRON: $60.76 vs. KALV: $15.82)
Brand notoriety: IRON and KALV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IRON: 61% vs. KALV: 86%
Market capitalization -- IRON: $2.11B vs. KALV: $796.38M
IRON [@Biotechnology] is valued at $2.11B. KALV’s [@Biotechnology] market capitalization is $796.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRON’s FA Score shows that 0 FA rating(s) are green whileKALV’s FA Score has 0 green FA rating(s).

  • IRON’s FA Score: 0 green, 5 red.
  • KALV’s FA Score: 0 green, 5 red.
According to our system of comparison, IRON is a better buy in the long-term than KALV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRON’s TA Score shows that 6 TA indicator(s) are bullish while KALV’s TA Score has 5 bullish TA indicator(s).

  • IRON’s TA Score: 6 bullish, 2 bearish.
  • KALV’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IRON is a better buy in the short-term than KALV.

Price Growth

IRON (@Biotechnology) experienced а +1.87% price change this week, while KALV (@Biotechnology) price change was +17.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

IRON is expected to report earnings on Nov 06, 2025.

KALV is expected to report earnings on Sep 11, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($2.11B) has a higher market cap than KALV($796M). KALV YTD gains are higher at: 86.777 vs. IRON (-4.164). IRON has higher annual earnings (EBITDA): -142.42M vs. KALV (-173.33M). IRON has more cash in the bank: 650M vs. KALV (221M). KALV has less debt than IRON: KALV (6.31M) vs IRON (30.9M). IRON (0) and KALV (0) have equivalent revenues.
IRONKALVIRON / KALV
Capitalization2.11B796M265%
EBITDA-142.42M-173.33M82%
Gain YTD-4.16486.777-5%
P/E RatioN/AN/A-
Revenue00-
Total Cash650M221M294%
Total Debt30.9M6.31M490%
FUNDAMENTALS RATINGS
KALV: Fundamental Ratings
KALV
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
89
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IRONKALV
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
75%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 1 day ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
81%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KALV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DQIRX34.56N/A
N/A
BNY Mellon Equity Income Fund I
SRIDX14.68N/A
N/A
Gabelli SRI I
MKVEX16.60N/A
N/A
MFS International Large Cap Value R2
GSTIX15.16-0.02
-0.13%
Goldman Sachs Strategic Growth Instl
BPSIX28.31-0.05
-0.18%
Boston Partners Small Cap Value II I

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with SYRE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
+0.95%
SYRE - IRON
53%
Loosely correlated
+0.06%
IDYA - IRON
51%
Loosely correlated
+5.15%
CGON - IRON
51%
Loosely correlated
+6.88%
CRNX - IRON
50%
Loosely correlated
+3.97%
ERAS - IRON
49%
Loosely correlated
+8.78%
More

KALV and

Correlation & Price change

A.I.dvisor indicates that over the last year, KALV has been loosely correlated with ATXS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if KALV jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALV
1D Price
Change %
KALV100%
+4.08%
ATXS - KALV
46%
Loosely correlated
+7.43%
COGT - KALV
43%
Loosely correlated
+0.85%
IRON - KALV
41%
Loosely correlated
+0.95%
IDYA - KALV
40%
Loosely correlated
+5.15%
SYRE - KALV
39%
Loosely correlated
+0.06%
More